Enlivex Therapeutics
Latest round
- Series B
Last raised
- Sep 2017
Total raised
- $8M
Investors
- 2
About Enlivex Therapeutics
Enlivex Therapeutics Ltd.Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Jerusalem, Israel. The company focuses on innovative treatments for inflammatory diseases using its proprietary Allocetra™ platform. and Korea Investment Partners.Enlivex Therapeutics Ltd. is dedicated to the development and commercialization of its proprietary cell therapy platform, Allocetra™, aimed at treating various inflammatory diseases. Allocetra™ employs a unique therapeutic mechanism that leverages the natural healing capabilities of macrophages to manage both acute conditions like sepsis and long-term inflammatory diseases such as osteoarthritis. The therapy can be administered via systemic intravenous infusion or through targeted local injections, making it versatile for different medical situations.Enlivex Therapeutics operates a revenue model centered around the development and eventual commercialization of its leading product, Allocetra™. Expected revenue streams will arise from partnerships with healthcare institutions and research organizations involved in clinical trials, alongside future sales following regulatory approvals. The structure of these transactions will likely include direct agreements with hospitals and clinics, leveraging both B2B and direct-to-consumer channels once Allocetra™ is commercially available. The company aims to expand its reach into new geographic regions, specifically targeting additional markets in Europe and Asia by the end of 2023.
Who invested in Enlivex Therapeutics
2 investors across 1 round
See all investors in Enlivex Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 19, 2017
Amount
$8M
Investors
Questions about Enlivex Therapeutics
Who invested in Enlivex Therapeutics?
Enlivex Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enlivex Therapeutics raised?
Enlivex Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Enlivex Therapeutics last raise money?
Enlivex Therapeutics's most recent round on record is a Series B, in Sep 2017.
What does Enlivex Therapeutics do?
Enlivex Therapeutics is a biotechnology company.
Where is Enlivex Therapeutics headquartered?
Enlivex Therapeutics is headquartered in Jerusalem, Israel.
Which VCs invest in companies like Enlivex Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Enlivex Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Enlivex Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.